A Phase 3, Prospective, Double-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection as compared to saline placebo injection in the treatment of plantar fasciitis.
Principal Investigator(s)
Email for information
Funded by
Geneva
Research Start Date
Status
Inactive
The primary objective of this study is to determine the safety and effectiveness of AmnioFix Injectable as compared to the 0.9% Sodium Chloride Injection, USP placebo control for the treatment of moderate to severe pain due to plantar fasciitis.
The appearance of name-brand products in this article does not constitute endorsement by Brooke Army Medical Center, the U.S. Army Medical Center, the U.S. Army Medical Department, the U.S. Army Office of the Surgeon General, the Department of the Army, the Department of Defense, or the U.S. Government of the information, products, or services contained therein.